TAXOTERE Safety Questions, TAXOTERE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TAXOTERE. Our extensive database of TAXOTERE adverse events and TAXOTERE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TAXOTERE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TAXOTERE Safety Reports

Total TAXOTERE reports: 658.
TAXOTERE FDA safety alerts: 2001 .
Reported deaths: 210    Reported hospitalizations: 334.
Take TAXOTERE Side Effects Survey or Share Your TAXOTERE Story. Read More Here.

Showing 1-75 of 658 Next >

Physician from JAPAN reported TAXOTERE problem on Feb 20, 2007. Male patient, 84 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: ileus, sepsis, white blood cell count decreased. TAXOTERE dosage: unknown. During the same period patient was treated with OXYCONTIN, VITAMEDIN, CLARITHROMYCIN, GASTER, NAIXAN, RINDERON, BIOFERMIN R. Patient died on 01/22/2007.

TAXOTERE problem was reported by a Physician from ITALY on Feb 19, 2007. Male patient, 69 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. TAXOTERE dosage: unknown. During the same period patient was treated with ENDOXAN, DELTACORTENE, CLEXANE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Feb 20, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cataract, visual disturbance. TAXOTERE dosage: unknown. Patient recovered.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Male patient, 69 years of age, weighting 154.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, dysphagia, dyspnoea, enteritis, febrile neutropenia, haematemesis, hepatic failure. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, LISINOPRIL, ASPIRIN, FLOMAX, OXYCODONE. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported TAXOTERE problem on Feb 20, 2007. Male patient, 57 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. TAXOTERE dosage: unknown. During the same period patient was treated with OLMETEC, ATELEC, KYTRIL, DECADRON. Patient recovered.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Female patient, weighting 169.0 lb, was diagnosed with ovarian cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: flushing, rash. TAXOTERE dosage: 100 MG IV Q 3 WKS. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Mar 02, 2007. Male patient, weighting 170.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, confusional state, dehydration, dysphasia. TAXOTERE dosage: 129 MG. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Health Professional from SWITZERLAND on Feb 20, 2007. Male patient, 61 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: urinary tract neoplasm. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, PANTOZOL, CONCOR, MARCUMAR. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Feb 23, 2007. Female patient, 53 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation. TAXOTERE dosage: DOSE: 75 MG/M2. During the same period patient was treated with HERCEPTIN. Patient died.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Feb 23, 2007. Male patient, 69 years of age, weighting 154.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, dysphagia, dyspnoea, enteritis, febrile neutropenia, gastritis haemorrhagic, haematemesis. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, LISINOPRIL, ASPIRIN, FLOMAX, OXYCODONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 02, 2007. Female patient, weighting 119.9 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: asthenia, chills, constipation, febrile neutropenia, pyrexia, white blood cell count decreased. TAXOTERE dosage: 75 MG/M2 Q 3 WK IV. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from on Feb 27, 2007. Female patient, 73 years of age, weighting 198.4 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cardiac arrest. TAXOTERE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE, ACETAMINOPHEN, ROSUVASTATIN CALCIUM, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported TAXOTERE problem on Feb 27, 2007. Female patient, 55 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: acute leukaemia. TAXOTERE dosage: unknown. During the same period patient was treated with NEULASTA, FARMORUBICINE. Patient was hospitalized. Patient died on 01/25/2007.

TAXOTERE problem was reported by a Consumer or non-health professional from on Feb 28, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, stomatitis necrotising. TAXOTERE dosage: unknown. During the same period patient was treated with ZOMETA, ZOLADEX, NOVANTRONE, ANDROCUR, ESTRACYT. Patient was hospitalized. Patient died on 10/01/2006.

Physician from UNITED KINGDOM reported TAXOTERE problem on Feb 26, 2007. Female patient, 50 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, blood albumin decreased, diarrhoea, fluid retention, hepatic function abnormal, hepatic pain, malaise, neutropenia. TAXOTERE dosage: unknown. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 39 years of age, weighting 120.0 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, chest pain, erythema, infusion related reaction, presyncope. TAXOTERE dosage: unknown. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Feb 27, 2007. Male patient, 84 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: ileus, sepsis, white blood cell count decreased. TAXOTERE dosage: unknown. During the same period patient was treated with OXYCONTIN, VITAMEDIN, CLARITHROMYCIN, GASTER, NAIXAN, RINDERON, BIOFERMIN R. Patient died on 01/22/2007.

TAXOTERE problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, neutropenia, optic ischaemic neuropathy, papilloedema, photopsia, pupillary reflex impaired, visual acuity reduced, visual field defect. TAXOTERE dosage: unknown. During the same period patient was treated with CYTOXAN, ADRIAMYCIN, VITAMINS, ASMANEX TWISTHALER, ASTELIN, ALAVERT, IMODIUM. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 01, 2007. Female patient, 56 years of age, weighting 166.0 lb, was diagnosed with breast cancer, hypertension, conjunctivitis and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: skin maceration, vaginal haemorrhage, vaginal pain. TAXOTERE dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, NORVASC, GEMFIBROZIL, PRINIVIL, COUMADIN, NEURONTIN, GLYBURIDE, GENTAMICIN. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Health Professional from ITALY on Feb 28, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer, thrombosis and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. TAXOTERE dosage: unknown. During the same period patient was treated with ENDOXAN, DELTACORTENE, CLEXANE. Patient was hospitalized. Patient died on 02/21/2007.

Pharmacist from JAPAN reported TAXOTERE problem on Feb 28, 2007. Male patient, 57 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. TAXOTERE dosage: unknown. During the same period patient was treated with OLMETEC, ATELEC, KYTRIL, DECADRON. Patient recovered.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, 55 years of age, weighting 198.4 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: atrial flutter, hypokalaemia, palpitations, sinus tachycardia. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, NEULASTA, LOPID, CLONIDINE, POTASSIUM CHLORIDE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Health Professional from reported TAXOTERE problem on Mar 02, 2007. Female patient, 58 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaemia, diabetic ketoacidosis, neutropenia, sepsis. TAXOTERE dosage: unknown. During the same period patient was treated with CAPECITABINE, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE, NORVASC, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient died on 02/07/2007.

TAXOTERE problem was reported by a Health Professional from ISRAEL on Feb 28, 2007. Male patient, weighting 185.2 lb, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. TAXOTERE dosage: unknown. During the same period patient was treated with GASTRO, SIMVACOR, ENALADEX, LEUPROLIDE ACETATE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 07, 2007. Male patient, weighting 321.0 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. TAXOTERE dosage: 56MG WEEKLY X 7 IV. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2007. Male patient, 71 years of age, was diagnosed with oesophageal carcinoma and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. TAXOTERE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 01, 2007. Male patient, 61 years of age, weighting 169.8 lb, was diagnosed with prostate cancer, nausea, cough and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: bladder perforation. TAXOTERE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ASPIRIN, ATIVAN, COMPAZINE, DECADRON, FISH OIL, GLUCOSAMINE, HYCODAN. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 40 years of age, weighting 92.59 lb, was diagnosed with insomnia, lymphangiosis carcinomatosa and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. TAXOTERE dosage: DOSE: 70MG/BODY. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MORPHES, DEPAS, PREDONINE, OMEPRAL, SOL MEDROL, SOL MEDROL. Patient died on 02/22/2007.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 08, 2007. Female patient, 42 years of age, weighting 119.0 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, erythema, flushing. TAXOTERE dosage: 113 MG EVERY 4 WEEKS IV. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from ITALY on Feb 27, 2007. Female patient, 62 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow toxicity, cardiac failure, leukopenia, neutropenia, oedema peripheral, petechiae. TAXOTERE dosage: 42.5 MG. During the same period patient was treated with CISPLATIN, GEMZAR, MELOXICAM, PREGABALIN, LEVODROPROPIZINE, ASPIRIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Mar 07, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TAXOTERE dosage: unknown. Patient died on 02/03/2007.

TAXOTERE problem was reported by a Physician from JAPAN on Mar 07, 2007. Female patient, 50 years of age, weighting 97.00 lb, was diagnosed with vomiting, myalgia and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased. TAXOTERE dosage: unknown. During the same period patient was treated with PROTECADIN, ZOFRAN, DECADRON, LOXONIN, PREDONINE. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Mar 08, 2007. Female patient, 47 years of age, weighting 108.0 lb, was diagnosed with breast cancer stage ii and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: arthritis. TAXOTERE dosage: unknown. During the same period patient was treated with FARMORUBICIN, ENDOXAN, FLUOROURACIL. Patient recovered.

TAXOTERE problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 53 years of age, weighting 136.7 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, pleural effusion. TAXOTERE dosage: unknown. During the same period patient was treated with HERCEPTIN, LOXOPROFEN, OXYCONTIN, DECADRON. Patient died on 08/03/2006.

Pharmacist from UNITED KINGDOM reported TAXOTERE problem on Mar 08, 2007. Female patient, 70 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation. TAXOTERE dosage: unknown. Patient died.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Mar 05, 2007. Female patient, 53 years of age, weighting 155.0 lb, was diagnosed with ovarian cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, impaired healing, wound evisceration. TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN, BEVACIZUMAB. Patient recovered.

Physician from UNITED KINGDOM reported TAXOTERE problem on Mar 07, 2007. Female patient, 50 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, blood albumin decreased, diarrhoea, fluid retention, hepatic function abnormal, hepatic pain, malaise, neutropenia. TAXOTERE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 72 years of age, weighting 321.9 lb, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: endocarditis, infection, panophthalmitis, pyrexia, renal failure, sepsis. TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN, NEULASTA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported TAXOTERE problem on Mar 09, 2007. Male patient, 51 years of age, weighting 156.5 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative, diarrhoea, febrile neutropenia, mucosal inflammation, renal failure acute, sepsis. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, NAVELBINE, SKENAN, ACTISKENAN, XATRAL, KETOPROFEN, PLAVIX, NOCTAMIDE. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Female patient, weighting 197.8 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cerebral ischaemia, decreased appetite, hypoglycaemia, hypotension, hypoxia, metastases to spine, nausea, oral intake reduced. TAXOTERE dosage: 145 MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported TAXOTERE problem on Mar 08, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture. TAXOTERE dosage: unknown. During the same period patient was treated with DOLCONTIN, SIMVASTATIN, ENALAPRIL MALEATE, SALURES, TEMESTA, ZOLPIDEM TARTRATE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 73 years of age, weighting 161.0 lb, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: back pain, dehydration, renal failure. TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TAXOTERE problem on Mar 14, 2007. Female patient, 50 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: confusional state, nervous system disorder. TAXOTERE dosage: unknown. During the same period patient was treated with ERBITUX. Patient recovered.

TAXOTERE problem was reported by a Pharmacist from UNITED KINGDOM on Mar 12, 2007. Female patient, 44 years of age, weighting 183.0 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: arthralgia, carpal tunnel syndrome, hypoaesthesia, myalgia, neuropathy peripheral, skin exfoliation. TAXOTERE dosage: unknown. During the same period patient was treated with HERCEPTIN, VOLTAREN, CODYDRAMOL, TRAMADOL, AMITRIPTYLINE. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Mar 13, 2007. Male patient, 40 years of age, weighting 92.59 lb, was diagnosed with insomnia, lymphangiosis carcinomatosa and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: disease progression, haemolytic anaemia. TAXOTERE dosage: DOSE: 70MG/BODY. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MORPHES, DEPAS, PREDONINE, OMEPRAL, SOL MEDROL, SOL MEDROL. Patient died on 02/22/2007.

TAXOTERE problem was reported by a Physician from GERMANY on Mar 09, 2007. Female patient was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary vasculitis. TAXOTERE dosage: unknown. Patient recovered.

Physician from GERMANY reported TAXOTERE problem on Mar 12, 2007. Female patient, 63 years of age, weighting 194.0 lb, was diagnosed with breast cancer, prophylaxis and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: depression, diarrhoea, dizziness, leukopenia, stomatitis. TAXOTERE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NEUPOGEN, ANTIEMETICS AND ANTINAUSEANTS, ANTIHISTAMINES. Patient recovered.

TAXOTERE problem was reported by a Pharmacist from JAPAN on Mar 15, 2007. Male patient, 79 years of age, was diagnosed with insomnia and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TAXOTERE dosage: unknown. During the same period patient was treated with RHYTHMY, ENDOXAN. Patient died on 02/18/2007.

Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Mar 19, 2007. Male patient, 57 years of age, weighting 117.5 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hypotension, neutropenia, pyrexia. TAXOTERE dosage: unknown. During the same period patient was treated with FILGRASTIM, CEFEPIME. Patient was hospitalized. Patient died on 11/24/2006.

TAXOTERE problem was reported by a Consumer or non-health professional from on Mar 15, 2007. Female patient, 73 years of age, weighting 198.4 lb, was diagnosed with breast cancer, diabetes mellitus, pain, dyslipidaemia, mastitis and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cardiac arrest. TAXOTERE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE, ACETAMINOPHEN, ROSUVASTATIN CALCIUM, PREDNISOLONE, CIPROFLOXACIN, LORNOXICAM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 20, 2007. Male patient, weighting 199.7 lb, was diagnosed with bladder cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cough, fatigue, haematocrit decreased, neutropenia, platelet count increased, pyrexia, white blood cell count decreased. TAXOTERE dosage: 75 MG/M2 IVB Q 21 DAYS. During the same period patient was treated with ZACTIMA, PROTONIX. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Pharmacist from JAPAN on Mar 14, 2007. Male patient, 65 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TAXOTERE dosage: unknown. During the same period patient was treated with ADONA, TRANSAMIN, MOBIC, ADALAT, PREDONINE, NAUZELIN, LOXOPROFEN, MUCOSTA. Patient died on 02/03/2007.

Pharmacist from GERMANY reported TAXOTERE problem on Oct 09, 2006. Female patient was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic cirrhosis. TAXOTERE dosage: unknown. Patient recovered.

TAXOTERE problem was reported by a Physician from JAPAN on Feb 13, 2007. Male patient, 84 years of age, weighting 105.8 lb, was diagnosed with pain and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: ileus. TAXOTERE dosage: unknown. During the same period patient was treated with OXYCONTIN, VITAMEDIN, CLARITHROMYCIN, GASTER, NAIXAN, RINDERON, BIOFERMIN R. Patient died on 01/22/2007.

Physician from JAPAN reported TAXOTERE problem on Jan 25, 2007. Male patient, 79 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TAXOTERE dosage: unknown. During the same period patient was treated with VINORELBINE. Patient died.

TAXOTERE problem was reported by a Pharmacist from JAPAN on Mar 14, 2007. Female patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: asthenia, fall, neuropathy peripheral, tinnitus. TAXOTERE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 15, 2007. Female patient, 71 years of age, weighting 94.80 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypokalaemia, nausea, vomiting. TAXOTERE dosage: unknown. During the same period patient was treated with FLUOROURACIL, HYDROXYUREA. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from on Mar 20, 2007. Female patient, 58 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: arthritis. TAXOTERE dosage: unknown. During the same period patient was treated with HERCEPTIN, CYCLOPHOSPHAMIDE, FLUOROURACIL, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 22, 2007. Male patient, 64 years of age, weighting 270.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anorexia, chest pain, conjunctivitis, dermatitis infected, dyspnoea, mucosal inflammation, myocardial infarction, oral pain, pneumonia. TAXOTERE dosage: unknown. During the same period patient was treated with CETUXIMAB, NIFEDIPINE, LOVASTATIN, LISINOPRIL, OXYCODONE. Patient was hospitalized. Patient died on 12/09/2006.

TAXOTERE problem was reported by a Pharmacist from UNITED KINGDOM on Mar 21, 2007. Female patient, 18 years of age, weighting 147.7 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: eye inflammation, eye irritation, eye pruritus, eye swelling, eyelid margin crusting, lacrimation increased. TAXOTERE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 20, 2007. Male patient, 72 years of age, weighting 321.9 lb, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, endocarditis, endophthalmitis, hypotension, panophthalmitis, pyrexia, renal failure, sepsis. TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN, NEULASTA. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Pharmacist from JAPAN on Mar 22, 2007. Male patient, 79 years of age, weighting 143.3 lb, was diagnosed with insomnia and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TAXOTERE dosage: unknown. During the same period patient was treated with RHYTHMY. Patient died on 02/18/2007.

Pharmacist from UNITED KINGDOM reported TAXOTERE problem on Mar 20, 2007. Female patient, 44 years of age, weighting 183.0 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: arthralgia, carpal tunnel syndrome, hypoaesthesia, myalgia, neuropathy peripheral, skin exfoliation. TAXOTERE dosage: unknown. During the same period patient was treated with HERCEPTIN, VOLTAREN, CODYDRAMOL, TRAMADOL, AMITRIPTYLINE. Patient recovered.

TAXOTERE problem was reported by a Health Professional from EGYPT on Mar 25, 2007. Female patient, 53 years of age, weighting 211.6 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, diarrhoea, febrile neutropenia, mucosal inflammation. TAXOTERE dosage: unknown. During the same period patient was treated with PLATINOL, FLUOROURACIL. Patient died on 09/17/2006.

Health Professional from UNITED STATES reported TAXOTERE problem on Mar 29, 2007. Male patient, 61 years of age, weighting 200.6 lb, was diagnosed with bladder cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: cough, fatigue, febrile neutropenia, haematocrit decreased, white blood cell count decreased. TAXOTERE dosage: 75 MG/M2 IVB Q 21 DAYS. During the same period patient was treated with PROTONIX. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2007. Male patient, weighting 168.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. TAXOTERE dosage: 139 MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Mar 30, 2007. Male patient, weighting 168.0 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. TAXOTERE dosage: 142 MG. Patient recovered.

TAXOTERE problem was reported by a Consumer or non-health professional from ITALY on Feb 27, 2007. Male patient, 62 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cardiac failure. TAXOTERE dosage: 42.5 MG. During the same period patient was treated with CISPLATIN, GEMZAR, MELOXICAM, PREGABALIN, LEVODROPROPIZINE, ASPIRIN. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TAXOTERE problem on Mar 23, 2007. Female patient, 50 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: confusional state, nervous system disorder. TAXOTERE dosage: unknown. During the same period patient was treated with ERBITUX. Patient recovered.

TAXOTERE problem was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, 41 years of age, weighting 92.59 lb, was diagnosed with insomnia, lymphangiosis carcinomatosa and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: disease progression, haemolytic anaemia. TAXOTERE dosage: DOSE: 70MG/BODY. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MORPHES, DEPAS, PREDONINE, OMEPRAL, SOL MEDROL, SOL MEDROL. Patient died on 02/22/2007.

Physician from reported TAXOTERE problem on Mar 26, 2007. Female patient, 58 years of age, was diagnosed with breast cancer, hiv infection and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. TAXOTERE dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

TAXOTERE problem was reported by a Health Professional from FRANCE on Mar 27, 2007. Male patient, 70 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hypotension, renal failure. TAXOTERE dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, COTAREG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TAXOTERE problem on Mar 26, 2007. Female patient, 55 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, stomatitis necrotising. TAXOTERE dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

TAXOTERE problem was reported by a Physician from JAPAN on Mar 28, 2007. Female patient, 47 years of age, weighting 108.0 lb, was diagnosed with breast cancer stage ii and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: arthritis. TAXOTERE dosage: unknown. During the same period patient was treated with ENDOXAN, FARMORUBICIN, FLUOROURACIL, DECADRON. Patient recovered.

Physician from JAPAN reported TAXOTERE problem on Mar 29, 2007. Male patient, 84 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: ileus, sepsis, white blood cell count decreased. TAXOTERE dosage: unknown. During the same period patient was treated with VITAMEDIN, CLARITHROMYCIN, GASTER, NAIXAN, RINDERON, BIOFERMIN R, CARBAZOCHROME SULFONATE, ALLOID G. Patient died on 01/23/2007.

Showing 1-75 of 658 Next >

Ask Our Patient Community about TAXOTERE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesar